Magnesium may modestly lower blood pressure

American Heart Association Rapid Access Journal Report

July 11, 2016 Categories: Heart News

Study Highlights

  • People receiving about 368 mg/day of magnesium for about three months had overall reductions in systolic blood pressure of 2.00 mm Hg and diastolic blood pressure of 1.78 mm Hg.
  • Magnesium might only be effective among people with magnesium deficiency or insufficiency.

Embargoed 3 p.m. CT / 4 p.m. ET Monday, July 11, 2016

DALLAS, July 11, 2016 – Magnesium, an essential element in the human body, may modestly lower blood pressure, according to research published in the American Heart Association’s journal Hypertension.

Magnesium is found in whole grains, beans, nuts and green leafy vegetables.

Researchers have long debated whether magnesium plays a role in regulating blood pressure with inconsistent and controversial evidence from studies in humans. This meta-analysis, however, collected data from 34 clinical trials, involving 2,028 participants, and found a small but significant association between magnesium intake and reduced blood pressure.

Researchers found:

  • people receiving a median of 368 milligrams (mg) of magnesium a day for an average of three months had overall reductions in systolic blood pressure of 2.00 millimeters of mercury (mm Hg) and diastolic blood pressure of 1.78 mm Hg.
  • taking 300 mg/day of magnesium for just one month was enough to elevate blood magnesium levels and reduce blood pressure.
  • high magnesium levels in the blood were linked to improvements in blood flow, another factor associated with lowered blood pressure.

The daily dosage of magnesium supplements in this study ranged from 240 to 960 mg, most of which (82 percent) were equal to or higher than the U.S. Recommended Dietary Allowance for adults (310 - 320 mg/day for women and 400 - 420 mg/day for men).

“With its relative safety and low cost, magnesium supplements could be considered as an option for lowering blood pressure in high-risk persons or hypertension patients,” said Yiqing Song, M.D., Sc.D., lead author and associate professor in the department of epidemiology at the Richard M. Fairbanks School of Public Health at Indiana University.

However, American Heart Association spokesperson Penny Kris-Etherton, Ph.D., noted that magnesium supplements are not necessary.

“This study underscores the importance of consuming a healthy diet that provides the recommended amount of magnesium as a strategy for helping to control blood pressure,” said Kris-Etherton, a distinguished professor of nutrition at the Pennsylvania State University. “Importantly, this amount of magnesium (368 mg/day) can be obtained from a healthy diet that is consistent with AHA dietary recommendations.”

The meta-analysis is limited by the small size of most of the studies (ranging from 13 to 461 participants) and by high dropout rates. Those studies that were higher quality and maintained lower dropout rates and showed the greatest reductions in blood pressure. In addition, when the researchers examined sub-groups of people in the studies, they discovered that added magnesium may only reduce blood pressure in people with magnesium deficiency.

“Consistent with previous studies, our evidence suggests that the anti-hypertensive effect of magnesium might be only effective among people with magnesium deficiency or insufficiency,” Song said. “Such suggestive evidence indicates that maintenance of optimal magnesium status in the human body may help prevent or treat hypertension.”

Co-authors are Xi Zhang, Ph.D.; Yufeng Li, M.D.; Liana C. Del Gobbo, Ph.D.; Andrea Rosanoff, Ph.D.; Jiawei Wang, Ph.D.; and Wen Zhang, Ph.D. Author disclosures are on the manuscript.

The Indiana University Health–Indiana University School of Medicine Strategic Research Initiative funded the study.

Additional Resources:

###

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policiesto prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.

For Media Inquiries and AHA/ASA Spokesperson Perspective: (214) 706-1173

Akeem Ranmal: (214) 706-1755; Akeem.ranmal@heart.org

Julie Del Barto (national broadcast): (214) 706-1330; julie.delbarto@heart.org

For Public Inquiries: (800)-AHA-USA1 (242-8721)

heart.org and strokeassociation.org

Life is why, science is how . . . we help people live longer, healthier lives.